Cargando…
Clinical Pharmacology and Safety of Trifarotene, a First‐in‐Class RARγ‐Selective Topical Retinoid
Trifarotene is a new drug with retinoic acid receptor activity and selectivity for retinoic acid receptor‐γ. The reported studies aimed at assessing the clinical pharmacology and safety of trifarotene. The clinical pharmacology of topical trifarotene up to 100 µg/g was extensively investigated throu...
Autores principales: | Wagner, Nathalie, Benkali, Khaled, Alió Sáenz, Alessandra, Poncet, Michel, Graeber, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187247/ https://www.ncbi.nlm.nih.gov/pubmed/32017149 http://dx.doi.org/10.1002/jcph.1566 |
Ejemplares similares
-
Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne
por: Blume‐Peytavi, U., et al.
Publicado: (2019) -
Trifarotene for acne
Publicado: (2021) -
Trifarotene for acne [Correction]
Publicado: (2022) -
Management of Acne Vulgaris With Trifarotene
por: Tan, Jerry, et al.
Publicado: (2023) -
Trifarotene: A Current Review and Perspectives in Dermatology
por: Cosio, Terenzio, et al.
Publicado: (2021)